AstraZeneca’s coronavirus vaccine suffered a setback that shows why Big Pharma would rather be safe than sorry. Here’s the good news.

2020-09-09

  U.K.-based pharmaceutical giant AstraZeneca said Tuesday it will suspend clinical trials of a coronavirus vaccine it developed with Oxford University after a British subject fell ill. The decision will affect the company’s just-started so-called Phase 3 trial, which recruited 30,000 volunteers in the U.S. after 10,000 subjects in theRead More →

Companies race to find the key to eternal life

2019-08-25

Getty Images The fountain of eternal youth once sounded like pure science fiction, but now investors are pouring millions into start-ups searching for revolutionary ways to reverse the aging process. The big hope is that they will one day become a reality and turn a profit. On Monday, Juvenescence: TheRead More →

Health-care drama has now spread to biopharma stocks

2019-04-18

Health stocks had another bad day, with investor jitters spreading to the biotech and pharmaceutical sectors, as well. Investors’ anxiety seemed to have expanded from health retailers, managed care companies and health insurers to include biopharma companies on Thursday. The three biggest losers in the Health Care Select Sector SPDRRead More →

5 things to know about Hookipa Pharma ahead of its IPO

2019-04-17

Hookipa Pharma Inc., a biotech that’s using arenavirus-based platforms to develop treatments targeting infectious diseases and cancers, priced its initial public offering on the low end of its range late Wednesday. The company said it will sell 6 million shares at $14 each, after previously saying it would offer 6.7Read More →